ArticleNature neuroscience2026
Laser-engineered PRIME fiber for panoramic reconfigurable control of neural activity.
Article in Nature neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Understanding the neural basis of behavior requires tools to flexibly control neural activity across distributed circuits. Optical methods enable precise, cell-type-specific control, but current fiber-based approaches deliver light to only a few fixed sites, limiting versatility. To address this, we developed 'panoramically reconfigurable illuminative' (PRIME), a single-fiber probe with over a thousand light-emitting sites distributed along its length and circumference, enabling panoramic and reconfigurable illumination from a single implant. We equipped a 160-μm multicore fiber with laser-engineered grating light emitters at designated axial and radial positions. By modulating input light patterns, PRIME dynamically switched illumination at 60 Hz among 1,200 sites spanning 5 mm and 360°. By integrating PRIME with high-density recording arrays, including Neuropixels, we demonstrated spatially targeted optogenetic activation alongside simultaneous electrophysiological recording in vivo. In freely moving mice, stimulation at different depths and locations within the superior colliculus evoked distinct defensive behaviors. PRIME's scalable and reconfigurable light delivery across large volumes offers a powerful platform for optical control of neural circuits across the brain.
Indexed as
Identifiers
41174171What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.